Form 4 for ZLAB Zai Lab Ltd
Accepted 2021-09-10 00:00:00 ET · period of report 2021-09-09 · accession 0001567619-21-016964 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-10 | 2021-09-09 | ZLAB | Reinhart Harald | Chief Medical Off | M - OptEx | $3.00 | +10.0K | 10.0K | New | +$30.0K |
| DM | 2021-09-10 | 2021-09-09 | ZLAB | Reinhart Harald | Chief Medical Off | S - Sale+OE | $141.36 | -10.0K | 1,900 | -84% | -$1.41M |
| D | 2021-09-10 | 2021-09-09 | ZLAB | Reinhart Harald | Chief Medical Off | M - OptEx | $0.00 | -10.0K | 13.3K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-09-09 | M | A | 10,000 | $3.00 | 10,000 | D | — | — | |
| 2 | Common | Ordinary Shares | 2021-09-09 | S | D | 2,731 | $137.39 | 7,269 | D | — | — | (F2) Reflects a weighted average sale price of $137.39 per share, at prices ranging from $136.81 to $137.74 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Ordinary Shares | 2021-09-09 | S | D | 900 | $138.33 | 6,369 | D | — | — | (F3) Reflects a weighted average sale price of $138.33 per share, at prices ranging from $137.89 to $138.67 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Ordinary Shares | 2021-09-09 | S | D | 569 | $139.27 | 5,800 | D | — | — | (F4) Reflects a weighted average sale price of $139.27 per share, at prices ranging from $139.05 to $139.36 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Ordinary Shares | 2021-09-09 | S | D | 800 | $140.87 | 5,000 | D | — | — | (F5) Reflects a weighted average sale price of $140.87 per share, at prices ranging from $140.47 to $141.26 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Common | Ordinary Shares | 2021-09-09 | S | D | 700 | $141.92 | 4,300 | D | — | — | (F6) Reflects a weighted average sale price of $141.92 per share, at prices ranging from $141.47 to $142.30 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 7 | Common | Ordinary Shares | 2021-09-09 | S | D | 1,600 | $143.34 | 2,700 | D | — | — | (F7) Reflects a weighted average sale price of $143.34 per share, at prices ranging from $142.81 to $143.72 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 8 | Common | Ordinary Shares | 2021-09-09 | S | D | 500 | $146.61 | 0 | D | — | — | (F10) Reflects a weighted average sale price of $146.61 per share, at prices ranging from $146.50 to $146.76 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 9 | Common | Ordinary Shares | 2021-09-09 | S | D | 1,400 | $146.07 | 500 | D | — | — | (F9) Reflects a weighted average sale price of $146.07 per share, at prices ranging from $145.49 to $146.46 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 10 | Common | Ordinary Shares | 2021-09-09 | S | D | 800 | $144.35 | 1,900 | D | — | — | (F8) Reflects a weighted average sale price of $144.35 per share, at prices ranging from $144.09 to $144.99 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 11 | Derivative | Stock Options (Right to Buy) | 2021-09-09 | M | D | 10,000 | $0.00 | 13,334 | D | $3.00 · — to 2027-05-12 | 10,000 Ordinary Shares | (F11) The options vest in equal annual installments over four years beginning on 5/12/2018, the first anniversary of the date of grant. |